On the recordMarch 30, 2023
In the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price.
Source
congress.govIn the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price.
Discusses findings from an investigation into insulin pricing.
Share
More from Chuck Grassley
The Judiciary Committee stands ready to advance President Trump's next Attorney General nominee.
The FBI’s actions were an unconstitutional breach, and Attorney General Bondi and [FBI] Director [Kash] Patel need to hold accountable those involved in this serious wrongdoing.
I was offended by what the president said, and I’m disappointed that it would result in personal insults.